Detail
Článek
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

S1PR1 drives a feedforward signalling loop to regulate BATF3 and the transcriptional programme of Hodgkin lymphoma cells

K. Vrzalikova, M. Ibrahim, M. Vockerodt, T. Perry, S. Margielewska, L. Lupino, E. Nagy, E. Soilleux, D. Liebelt, R. Hollows, A. Last, G. Reynolds, M. Abdullah, H. Curley, M. Care, D. Krappmann, R. Tooze, J. Allegood, S. Spiegel, W. Wei, CBJ....

. 2018 ; 32 (1) : 214-223. [pub] 20170907

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc19001198
E-zdroje Online Plný text

NLK ProQuest Central od 2000-01-01 do Před 1 rokem
Open Access Digital Library od 1997-01-01
Nursing & Allied Health Database (ProQuest) od 2000-01-01 do Před 1 rokem
Health & Medicine (ProQuest) od 2000-01-01 do Před 1 rokem
Public Health Database (ProQuest) od 2000-01-01 do Před 1 rokem

Odkazy

PubMed 28878352
DOI 10.1038/leu.2017.275
Knihovny.cz E-zdroje

The Hodgkin/Reed-Sternberg cells of classical Hodgkin lymphoma (HL) are characterised by the aberrant activation of multiple signalling pathways. Here we show that a subset of HL displays altered expression of sphingosine-1-phosphate (S1P) receptors (S1PR)s. S1P activates phosphatidylinositide 3-kinase (PI3-K) in these cells that is mediated by the increased expression of S1PR1 and the decreased expression of S1PR2. We also showed that genes regulated by the PI3-K signalling pathway in HL cell lines significantly overlap with the transcriptional programme of primary HRS cells. Genes upregulated by the PI3-K pathway included the basic leucine zipper transcription factor, ATF-like 3 (BATF3), which is normally associated with the development of dendritic cells. Immunohistochemistry confirmed that BATF3 was expressed in HRS cells of most HL cases. In contrast, in normal lymphoid tissues, BATF3 expression was confined to a small fraction of CD30-positive immunoblasts. Knockdown of BATF3 in HL cell lines revealed that BATF3 contributed to the transcriptional programme of primary HRS cells, including the upregulation of S1PR1. Our data suggest that disruption of this potentially oncogenic feedforward S1P signalling loop could provide novel therapeutic opportunities for patients with HL.

000      
00000naa a2200000 a 4500
001      
bmc19001198
003      
CZ-PrNML
005      
20190122100356.0
007      
ta
008      
190107s2018 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/leu.2017.275 $2 doi
035    __
$a (PubMed)28878352
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Vrzalikova, K $u Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
245    10
$a S1PR1 drives a feedforward signalling loop to regulate BATF3 and the transcriptional programme of Hodgkin lymphoma cells / $c K. Vrzalikova, M. Ibrahim, M. Vockerodt, T. Perry, S. Margielewska, L. Lupino, E. Nagy, E. Soilleux, D. Liebelt, R. Hollows, A. Last, G. Reynolds, M. Abdullah, H. Curley, M. Care, D. Krappmann, R. Tooze, J. Allegood, S. Spiegel, W. Wei, CBJ. Woodman, PG. Murray,
520    9_
$a The Hodgkin/Reed-Sternberg cells of classical Hodgkin lymphoma (HL) are characterised by the aberrant activation of multiple signalling pathways. Here we show that a subset of HL displays altered expression of sphingosine-1-phosphate (S1P) receptors (S1PR)s. S1P activates phosphatidylinositide 3-kinase (PI3-K) in these cells that is mediated by the increased expression of S1PR1 and the decreased expression of S1PR2. We also showed that genes regulated by the PI3-K signalling pathway in HL cell lines significantly overlap with the transcriptional programme of primary HRS cells. Genes upregulated by the PI3-K pathway included the basic leucine zipper transcription factor, ATF-like 3 (BATF3), which is normally associated with the development of dendritic cells. Immunohistochemistry confirmed that BATF3 was expressed in HRS cells of most HL cases. In contrast, in normal lymphoid tissues, BATF3 expression was confined to a small fraction of CD30-positive immunoblasts. Knockdown of BATF3 in HL cell lines revealed that BATF3 contributed to the transcriptional programme of primary HRS cells, including the upregulation of S1PR1. Our data suggest that disruption of this potentially oncogenic feedforward S1P signalling loop could provide novel therapeutic opportunities for patients with HL.
650    _2
$a transkripční faktory bZIP $x genetika $7 D050976
650    _2
$a buněčné linie $7 D002460
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a regulace genové exprese u nádorů $x genetika $7 D015972
650    _2
$a HEK293 buňky $7 D057809
650    _2
$a Hodgkinova nemoc $x genetika $7 D006689
650    _2
$a lidé $7 D006801
650    _2
$a fosfatidylinositol-3-kinasy $x genetika $7 D019869
650    _2
$a receptory lysosfingolipidů $x genetika $7 D049349
650    _2
$a signální transdukce $x genetika $7 D015398
650    _2
$a genetická transkripce $x genetika $7 D014158
650    _2
$a nádorové buňky kultivované $7 D014407
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Ibrahim, M $u Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
700    1_
$a Vockerodt, M $u Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK. Institute of Anatomy and Cell Biology, Georg-August University of Göttingen, Göttingen, Germany.
700    1_
$a Perry, T $u Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
700    1_
$a Margielewska, S $u Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
700    1_
$a Lupino, L $u Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
700    1_
$a Nagy, E $u Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
700    1_
$a Soilleux, E $u Department of Cellular Pathology, John Radcliffe Hospital, Oxford, UK.
700    1_
$a Liebelt, D $u Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
700    1_
$a Hollows, R $u Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
700    1_
$a Last, A $u Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
700    1_
$a Reynolds, G $u Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
700    1_
$a Abdullah, M $u Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK. Department of Pathology, Universiti Putra Malaysia, Selangor, Malaysia.
700    1_
$a Curley, H $u Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
700    1_
$a Care, M $u Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK.
700    1_
$a Krappmann, D $u Research Unit Cellular Signal Integration, Helmholtz Zentrum München, Neuherberg, Germany.
700    1_
$a Tooze, R $u Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK.
700    1_
$a Allegood, J $u Department of Biochemistry and Molecular Biology and Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, VA, USA.
700    1_
$a Spiegel, S $u Department of Biochemistry and Molecular Biology and Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, VA, USA.
700    1_
$a Wei, W $u Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK. Sheffield Institute of Translational Neuroscience, University of Sheffield, Sheffield, UK.
700    1_
$a Woodman, C B J $u Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
700    1_
$a Murray, P G $u Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK. Department of Clinical and Molecular Pathology, Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic.
773    0_
$w MED00003138 $t Leukemia $x 1476-5551 $g Roč. 32, č. 1 (2018), s. 214-223
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28878352 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190107 $b ABA008
991    __
$a 20190122100616 $b ABA008
999    __
$a ok $b bmc $g 1365097 $s 1039321
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 32 $c 1 $d 214-223 $e 20170907 $i 1476-5551 $m Leukemia $n Leukemia $x MED00003138
LZP    __
$a Pubmed-20190107

Najít záznam

Citační ukazatele

Možnosti archivace